Originally Published MX May/June 2006

BUSINESS DRIVERS

Radlink Inc. (Redondo Beach, CA), a manufacturer of digital medical imaging solutions, has elected A. Redmond Doms Jr. to its board of directors. Doms is a member of the project advisory committee for the Los Angeles County-University of Southern California Medical Center and is past president of the St. John's Hospital Foundation. Radlink, which provides medical film-to-digital image conversion, storage, and delivery services to healthcare providers, recently received FDA clearance for the sale and distribution of its computed radiography system.

Celsion Corp. (Columbia, MD), a developer of heat-activated cancer treatment systems, has appointed William Hahne, MD, as its vice president of clinical development and medical affairs and Christopher Black, PhD, as its executive director of preclinical research. Hahne was most recently vice president of clinical development at CuraGen Corp. (Branford, CT), and Black was a John E. Fogarty fellow and associate at the National Institutes of Health (Bethesda, MD).

Bio/Data Corp. (Horsham, PA), a manufacturer of hemostasis and platelet function medical laboratory products, has appointed its marketing manager, William M. Trolio, to the position of vice president. Trolio joined Bio/Data in 1997, following an 18-year career at Bassett Healthcare (Cooperstown, NY), where he integrated the company's clinical departments. In addition, Bio/Data announced the appointment of two new managers: Kay Callahan as customer care manager and Mason Loika as corporate communications manager.

David Floyd has been promoted to president of Abbott Spine, a business of Abbott Laboratories (Abbott Park, IL). He will head up the company's global operations and be responsible for its continued growth. Floyd, who joined the company as general manager of U.S. business in August 2005, has held executive positions at companies including AxioMed Spine Corp., Centerpulse Orthopedics, Zimmer USA, Orthologic Corp., and Sulzer Orthopedics. He replaces Jeff Binder, who has been appointed senior vice president of Abbott and president of Abbott Diagnostics.

Cardiac Science (Bothell, WA), a manufacturer of cardiac monitoring and defibrillation products, has named Garry Norris, Cheryl Shea, and Daphne Taylor to its senior executive staff. Norris has been appointed vice president of marketing, a role in which he will lead the global direction, execution, and management of all marketing activities. Prior to joining Cardiac Science, he served as global vice president and chief marketing officer of Eastman Kodak's health imaging division. Shea has been appointed vice president of regulatory affairs and quality assurance. Prior to joining Cardiac Science, Shea owned a consulting firm that provided services to medical device companies. Taylor has been appointed vice president and corporate controller, a role in which she will be responsible for the activities of Cardiac Science's accounting team. She was previously a vice president and corporate controller at a publicly held software and technology company.

Orthofix International NV (Huntersville, NC) has promoted chief operating officer Alan W. Milinazzo to group president and chief executive officer. He succeeds Charles W. Federico, who will remain a director of the company. Milinazzo, who joined Orthofix in September 2005, was formerly vice president of vascular business at Medtronic Inc. (Minneapolis), as well as vice president and general manager of its coronary and peripheral businesses. Prior to Medtronic, he spent 12 years in executive roles within Boston Scientific Corp. (Natick, MA). At press time, no successor to the COO position at Orthofix had been named.

Imalux Corp. (Cleveland), a medical device company focused on imaging systems based on optical coherence tomography, has elected Jerry C. Cirino as its president and chief executive officer. Cirino, who will also become a member of the company's board of directors, was most recently founding president and CEO of SourceOne Healthcare Technologies (Mentor, OH), which was formed in late 2002 through the merger of two competing medical imaging companies. The company was sold in November 2005. Prior to SourceOne, Cirino spent nearly 20 years with Marconi Medical Systems.

Antares Pharma Inc. (Exton, PA), a pharma product development company with drug-delivery systems and injectable device engineering capabilities, has appointed Robert F. Apple to the position of senior vice president and chief financial officer. He replaces Lawrence M. Christian, who has retired from his position of vice president of finance and CFO. Apple has held financial roles at several public biotech and technology companies.

Edward J. Ludwig, president and CEO of Becton Dickinson (Franklin Lakes, NJ), has taken the reins as chair of the AdvaMed board of directors. He succeeds Arthur D. Collins Jr., chairman and CEO of Medtronic Inc. (Minneapolis), whose tenure was marked by unprecedented growth in the association's membership. Additionally, Boston Scientific COO Paul LaViolette was named chair of AdvaMed's technology and regulation committee, Edwards Lifesciences chairman and CEO Michael A. Mussallem began his term as chair of the payment and healthcare delivery committee, and Stryker president and CEO Stephen P. MacMillan took over chairmanship of the international committee. Newly elected AdvaMed board members for 2006 are: Martin J. Emerson, CEO, American Medical Systems; Christopher M. Gleeson, president and CEO, Ventana Medical Systems Inc.; J. Michael McQuade, vice president, 3M Medical Division, 3M Health Care; Cary R. Rayment, president and CEO, Alcon Laboratories Inc.; and Michael J. Thomas, president and CEO, Sleep Solutions Inc.

Clarus Ventures (Cambridge, MA), a venture capital firm focused on life sciences, announced that Emmett Cunningham, MD, PhD; Michele Park, PhD; and Scott Requadt have joined the firm as principals. Danielle Bechard has joined as controller. Prior to joining Clarus, Cunningham was senior vice president of medical strategy at Eyetech Pharmaceuticals Inc. Park joins Clarus from Credit Suisse First Boston, where she was an analyst, and Requadt joins Clarus from TransForm Pharmaceuticals Inc., where he was director of business development. Bechard comes to Clarus from the McDonald's Corp., where she was responsible for franchisee analysis.

OraSure Technologies Inc. (Bethlehem, PA), a manufacturer of oral fluid diagnostics, has appointed Charles W. Patrick as a member of its board of directors. Patrick has experience managing high-growth diagnostic companies in the areas of sales, marketing, and global distribution. From 1990 to 2000, he served as vice president of sales and marketing for Biosite Diagnostics.

Roger L. Blaine, PhD, regulatory affairs manager at thermal analysis and rheology equipment supplier TA Instruments (New Castle, DE), has been elected to a term on the board of directors of ASTM International (Conshohocken, PA). ASTM International is a standards development and delivery organization whose standards are used in research and development, product testing, quality systems, and commercial transactions around the globe.

Joseph A. Mussey has been appointed to the board of directors of U.S. Spine (Boca Raton, FL), a developer of spinal implant technology. In his new role, Mussey will help execute an expansion plan that includes eight new product launches in the coming 18 months. Prior to U.S. Spine, he served as president and chief operating officer of Interpore Cross International, which was acquired by EBI, a subsidiary of Biomet Inc.

Tm Bioscience Corp. (Toronto), a developer of DNA-based genetic tests, announced that Trevor L. Hawkins, PhD, has resigned from the company's board of directors. "By sharing his deep understanding of the molecular diagnostics industry with us, Dr. Hawkins has significantly enhanced this company," said Greg Hines, president and CEO of Tm Bioscience. "Unfortunately, a change in employment and relocation to Europe has made it necessary for him to resign from our board."

AngioDynamics Inc. (Queensbury, NY), a manufacturer of devices for the diagnosis and treatment of peripheral vascular disease, has named Peter J. Graham to its board of directors. He fills the seat left vacant by Howard S. Stern, who passed away in late 2005. Graham, Stern's son-in-law, served as corporate counsel and secretary of AngioDynamics until the company separated from E-Z-EM Inc. in 2004.

Charles Prince, chief executive officer of Citigroup, has been elected to the board of directors of Johnson & Johnson (New Brunswick, NJ). "As a sitting CEO of a major multinational company, Chuck brings considerable understanding and insight of the complex issues that face global corporations today," said Johnson & Johnson chairman and CEO William C. Weldon. "His business acumen and breadth of experience will make an enormous contribution to Johnson & Johnson."

Affymetrix Inc. (Santa Clara, CA), developer of the GeneChip microarray technology, reports that Robert H. Trice, PhD, has been elected to its board of directors. Trice serves as senior vice president for business development at Lockheed Martin Corp., where he is responsible for worldwide new business development and operations.

Affinergy Inc. (Research Triangle Park, NC), a Duke University spinout that develops site-specific biological delivery systems, announced that Daniel A. Pelak has joined its board of directors. Pelak is CEO of IRM Inc., a privately held medical device company pioneering a treatment for patients with heart disease. Prior to IRM, he was CEO of Closure Medical, which was recently acquired by Johnson & Johnson.

AtriCure Inc. (West Chester, OH), a manufacturer of surgical tissue-ablation devices, has appointed Mark R. Lanning to its board of directors. Lanning, who will serve on AtriCure's audit committee, is vice president and treasurer of Hillenbrand Industries Inc. (Batesville, IN).

California Healthcare Institute (La Jolla, CA), a nonprofit public policy research organization, has elected Ted W. Love, MD, and Joseph A. Akers to its board of directors. Love serves as chairman and CEO of biopharmaceutical company Nuvelo Inc. (San Carlos, CA), and Akers is president of Bayer Healthcare Pharmaceuticals, Hematology-Cardiology (Berkeley, CA).

Copyright ©2006 MX